Literature DB >> 3925340

Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9.

R R Chilcote, E Brown, J D Rowley.   

Abstract

Patients with acute lymphoblastic leukemia (ALL) who present with bulky disease of the lymph nodes, spleen, or mediastinum--so-called "lymphomatous ALL"--appear to represent a distinct subgroup among patients with ALL of T-cell lineage who have different clinical findings, but the biologic basis for these differences is not known. While studying 65 patients with lymphoblastic leukemia whose karyotype was determined at diagnosis, we compared the findings in 8 patients with lymphomatous ALL and 57 patients whose presentations were more typical of ALL. Six patients with lymphomatous ALL had karyotypic abnormalities leading to loss of bands p21-p22 on the short arm of chromosome 9. The mechanisms varied and included deletions, unbalanced translocations, or loss of the entire chromosome. Only 1 of the 57 patients without lymphomatous ALL had an abnormality of chromosome 9 at diagnosis (P less than 0.001). These findings indicate that loss of chromosomal material in the region of 9p21-p22 is closely associated with lymphomatous ALL; by analogy with retinoblastoma, in which gene deletions are associated with an enzyme deficiency, this disease may be related to the loss of the enzyme methylthioadenosine phosphorylase, previously reported in some of these patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925340     DOI: 10.1056/NEJM198508013130503

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  A polymorphic region defined by pCN2 (the 3' nontranslated region of N-ras) maps to chromosome 9cen-p12.

Authors:  T Nobori; L E Hexdall; D A Carson
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 2.  Progress against cancer.

Authors:  S Broder; J E Karp
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of beta-interferon gene in chronic myelogenous leukemia.

Authors:  A Neubauer; B Neubauer; E Liu
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

Review 4.  Sulphane sulphur in biological systems: a possible regulatory role.

Authors:  J I Toohey
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

5.  Chromosome analysis of 30 cases of non-Hodgkin's lymphoma.

Authors:  G Chenevix-Trench; J A Brown; G B Tyler; F G Behm
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

6.  The molecular biology of chromosome alterations in myelogenous leukemia.

Authors:  H A Drabkin
Journal:  West J Med       Date:  1985-12

Review 7.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

8.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

9.  Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.

Authors:  M O Diaz; S Ziemin; M M Le Beau; P Pitha; S D Smith; R R Chilcote; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas.

Authors:  S H Bigner; H S Friedman; J A Biegel; C J Wikstrand; J Mark; R Gebhardt; L F Eng; D D Bigner
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.